Amplitude Therapeutics
Cory Sago is the Chief Executive Officer and Founder of Amplitude Therapeutics, where activities are currently in stealth mode. Prior to this role, Cory served as Senior Director and Head of LNP Discovery at Beam Therapeutics, leading a team of over 20 to develop novel lipid nanoparticles for tissue delivery. As a co-founder and Chief Technology Officer of Guide Therapeutics, Cory contributed to advancing therapeutic solutions alongside Dr. James Dahlman. Academic experience includes a Doctor of Philosophy in Biomedical Engineering from Emory University and Georgia Institute of Technology, a Master's in Chemistry and Chemical Biology, and a Bachelor's in Biology from Rensselaer Polytechnic Institute. Early research involvement spans various laboratories, focusing on drug delivery, tissue engineering, and cancer research.
This person is not in any teams
Amplitude Therapeutics
Amplitude Therapeutics is a seed-staged biotechnology company focusing on developing the next generation of RNAs to fully unlock the therapeutic potential of RNA biology. We are founded by leaders in the RNA and non-viral therapy fields and backed by premier Biotech VCs.